Compositions for treating viral infections
US5908855A · kind A · utility
32Cited by
10References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 16, 1996 |
| Grant date | Jun 1, 1999 |
| Priority date | — |
| Expiry date | Jul 16, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4196
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition for the treatment of cancers or tumors in mammals is disclosed which comprises 2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol and its derivatives. A chemotherapeutic agent can be used in conjunction with 2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol and its derivatives as can potentiators. 2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol and its derivatives can also be used to treat viral infections, either alone, in conjunction with other anti-viral agents or with a potentiator.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.